Back to Journals » Therapeutics and Clinical Risk Management » Volume 16

Tildrakizumab: An Evidence-Based Review of Its Use in the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis

Total article views   HTML views PDF downloads Totals
4,561 Dovepress* 3,741+ 898 4,639
PubMed Central* 820 165 985
Totals 4,561 1,063 5,624
*Since 24 September 2020

View citations on PubMed Central and Google Scholar